Xi Zhichao, Dai Rongchen, Ze Yufei, Jiang Xue, Liu Mengfan, Xu Hongxi
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, 201203, China.
Mol Cancer. 2025 Feb 26;24(1):57. doi: 10.1186/s12943-025-02245-6.
Lung cancer remains a major global health challenge and one of the leading causes of cancer-related deaths worldwide. Despite significant advancements in treatment, challenges such as drug resistance, side effects, metastasis and recurrence continue to impact patient outcomes and quality of life. In response, there is growing interest in complementary and integrative approaches to cancer care. Traditional Chinese medicine (TCM), with its long history, abundant clinical experience, holistic perspective and individualized approach, has garnered increasing attention for its role in lung cancer prevention and management. This review provides a comprehensive overview of the advances in TCM for lung cancer treatment, covering its theoretical foundation, treatment principles, clinical experiences and evidence supporting its efficacy. We also provide a systematic summary of the preclinical mechanisms, through which TCM impacts lung cancer, including the induction of cell death, reversal of drug resistance, inhibition of metastasis and modulation of immune responses. Additionally, future prospects for TCM in lung cancer treatment are discussed, offering insights into its expanded application and integration with modern medicine to address this challenging disease.
肺癌仍然是一项重大的全球健康挑战,也是全球癌症相关死亡的主要原因之一。尽管在治疗方面取得了重大进展,但耐药性、副作用、转移和复发等挑战继续影响患者的治疗效果和生活质量。对此,人们对癌症护理的补充和综合方法的兴趣与日俱增。中医历史悠久,临床经验丰富,视角整体,方法个体化,其在肺癌预防和管理中的作用日益受到关注。本综述全面概述了中医治疗肺癌的进展,涵盖其理论基础、治疗原则、临床经验以及支持其疗效的证据。我们还系统总结了中医影响肺癌的临床前机制,包括诱导细胞死亡、逆转耐药性、抑制转移和调节免疫反应。此外,还讨论了中医在肺癌治疗中的未来前景,为其扩大应用以及与现代医学相结合以应对这一具有挑战性的疾病提供了见解。